First-line (1L) nivolumab (NIVO) plus ipilimumab (IPI) plus chemotherapy (chemo) in Asian patients (pts) with advanced non-small cell lung cancer (NSCLC) from CheckMate 9LA-MedSci.cn

First-line (1L) nivolumab (NIVO) plus ipilimumab (IPI) plus chemotherapy (chemo) in Asian patients (pts) with advanced non-small cell lung cancer (NSCLC) from CheckMate 9LA

John, T; Sakai, H; Ikeda, S; Cheng, Y; Kasahara, K; Sato, Y; Nakahara, Y; Takeda, M; Kaneda, H; Zhang, H; Maemondo, M; Minato, K; Hisada, T; Misumi, Y; Satouchi, M; Hotta, K; Li, A; Oukessou, A; Lu, S

ANNALS OF ONCOLOGY, 2020; 31 (): S847

科室
- - 订阅+
  - 更多科室
工具
服务